Radio-immunoassay of atrial natriuretic peptide (ANP) and characterization of ANP immunoreactivity in human plasma and atrial tissue

References

• Goetz K L. Physiology and pathophysiology of atrial peptides. Am J Physiol 1988; 254: E1–15
   PubMed Web of Science ®Google Scholar
• Inagami T. Atrial natriuretic factor. J Biol Chem 1989; 264: 3043–46
   PubMed Web of Science ®Google Scholar
• Needleman P, Blaine E H, Greenwald J E, Michener M L, Saper C B, Stockmann P T, Tolunay H E. The biochemical pharmacology of atrial peptides. Ann Rev Pharm Tox 1989; 29: 23–54
   PubMed Web of Science ®Google Scholar
• Richards A M, McDonald D, Fitzpatrick M A, Nicholls M G, Espiner E A, Ikram H, Jans S, Grant S, Yandle T. Atrial natriuretic hormone has biological effects in man at physiological plasma concentrations. J Clin Endocrinol Metab 1988; 67: 1134–39
   PubMed Web of Science ®Google Scholar
• Richards A M. Atrial natriuretic factor administered to humans: 1984–1988. J Cardiovasc Pharmacol 1989; 13: S69–74, (suppl 6)
   Web of Science ®Google Scholar
• Northridge D B, Alabaster C T, Connell J MC, Dilly S G, Lever A F, Jardine A G, Barclay P L, Dargie H J, Findlay I L, Samuels G MR. Effects of UK 69 578: a novel atriopeptidase inhibitor. Lancet 1989; ii: 591–3
   Google Scholar
• De Bold A J, Borenstein H B, Veress A T, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myo-cardial extract in rats. Life Sci 1981; 28: 89–94
   PubMed Web of Science ®Google Scholar
• Kangawa K, Fukuda A, Matsuo H. Structural identification of β-and γ-human atrial natriuretic polypeptides. Nature 1985; 313: 397–400
   PubMed Web of Science ®Google Scholar
• Miyata A, Toshimori T, Hashiguchi T, Kangawa K, Matsuo H. Molecular forms of atrial natriuretic polypeptides circulating in human plasma. Biochem Biophys Res Commun 1987; 142: 461–7
   PubMed Web of Science ®Google Scholar
• Sugawara A, Nakao K, Morii N, Yamada T, Itoh H, Shiono S, Saito Y, Mukoyama M, Arai H, Nishimura K, Obata K, Yasue H, Ban T, Imura H. Synthesis of atrial natriuretic polypcptide in human failing hearts: evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of β-human ANP. J Clin Invest 1988; 81: 1962–70
   PubMed Web of Science ®Google Scholar
• Akimoto K, Miyata A, Kangawa K, Koga Y, Hayakawa K, Matsuo H. Molecular forms of atrial natriuretic peptide in the atrium of patients with cardiovascular disease. J Clin Endocrinol Metab 1988; 67: 93–7
   PubMed Web of Science ®Google Scholar
• Ando K, Hirata Y, Emori T, Shichiri M, Kurosawa T, Sato K, Marumo F. Circulating forms of human atrial natriurctic peptide in patients with congestive heart failure. J Clin Endocrinol Metah 1990; 70: 1603–7
   PubMed Web of Science ®Google Scholar
• Rankin A J. Mechanisms for the release of atrial natriuretic peptide. Can J Physiol Pharmacol 1987; 65: 1673–9
   PubMed Web of Science ®Google Scholar
• Ferrari R, Agnoletti G. Atrial natriuretic peptide: its mechanism of release from the atrium. Int J Cardiol 1989; 24: 41372–49
   Web of Science ®Google Scholar
• Winters C J, Sallman A L, Meadows J, Rico D M, Vesely D L. Two new hormones: prohormone atrial natriuretic peptidcs 1–30 and 31–67 circulate in man. Biochem Biophys Res Commun 1988; 150: 231–6
   PubMed Web of Science ®Google Scholar
• Buckley M G, Sagnella G A, Markandu N D, Singer D RJ, MacGregor G A. Concentrations of N-terminal proANP in human plasma: evidence for proANP (1–98) as the circulating form. Clin Chim Acta 1990; 191: 1–14
   PubMed Web of Science ®Google Scholar
• Gerhes A L, Vollmar A M. Degradation and clearance of atrial natriuretic factors (ANF). Life Sci 1990; 47: 1173–80
   PubMed Web of Science ®Google Scholar
• Crozier I G, Nicholls M G, Ikram H, Espiner E A, Yandle T G, Jans S. Atrial natriuretic peptide in humans: production and clearance by various tissues. Hypertension 1986; 8: 1111–5, (suppl II)
   Web of Science ®Google Scholar
• Schütten HJ, Henriksen J H, Warherg J. Organ extraction of atrial natriuretic peptide (ANP) in man: significance of sampling site. Clin Physiol 1987; 7: 125–32
   PubMedGoogle Scholar
• Kenny A J, Stephenson S L. Role of endopeptidase-24.11 in the inactivation of atrial natriuretic peptide. FEBS Lett 1988; 232: 1–8
   PubMed Web of Science ®Google Scholar
• Hunter W M, Greenwood F C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 1962; 194: 495–6
   PubMed Web of Science ®Google Scholar
• Oyama T, Kudo T, Kudo M, Matsuki A, Miyata T, Kangawa K, Matsuo H. Plasma concentration of α-human atrial natriuretic polypeptide (α-hANP) during cardiopulmonary bypass under fentanyl anaesthesia. Agressologie 1986; 27: 687–9
   PubMedGoogle Scholar
• Hedner J, Towle A, Saltzman L, Mueller R A, Norfleet E A, Watson C B, Hedner T. Changes in plasma atrial natriuretic peptide-immunoreactivity in patients undergoing coronary artery bypass graft placements. Regul Pept 1987; 17: 151–7
   PubMedGoogle Scholar
• Dewar M L, Walsh G, Chiu R CJ. Atrial natriuretic factor: response to cardiac operation. J Thorac Cardiovasc Surg 1988; 96: 266–70
   PubMed Web of Science ®Google Scholar
• Johnsson P, Messeter K, Ryding E, Kugelberg J, Stähl E. Cerebral vasoreactivity to carbon dioxide during cardiopulmonary perfusion at normothermia and hypothermia. Ann Thorac Surg 1989; 48: 769–75
   PubMed Web of Science ®Google Scholar
• Rodbard D. Statistical quality control and routine data processing for radioimmunoassays and immunoradiometric assays. Clin Chem 1974; 20: 1255–70
   PubMed Web of Science ®Google Scholar
• Nutt R F, Veber D F. Chemical synthesis and structure-activity relations for ANF analogues. Endocrinol Metab Clin North Am 1987; 16: 19–41
   PubMed Web of Science ®Google Scholar
• DiMaio J, Jaramillo J, Wernic D, Grenier L, Welehner E, Adams J. Synthesis and biological activity of atrial natriuretic factor analogues: effect of modifications to the disulfide bridge. J Med Chem 1990; 33: 661–7
   PubMed Web of Science ®Google Scholar
• Yamaji T, Ishibashi M, Takaku F. Atrial natriuretic factor in human blood. J Clin Invest 1985; 76: 1705–9
   PubMed Web of Science ®Google Scholar
• Schenker Y, Sider R S, Ostafin E A, Grekin R J. Plasma levels of immunoreactive atrial natriuretic factor in healthy subjects and in patients with edema. J Clin Invest 1985; 76: 1684–7
   PubMed Web of Science ®Google Scholar
• Lindberg B F, Andersson K-E. Adsorption of atrial natriuretic peptide to different materials: a factor influencing results of in vitro results. Pharmacol Toxicol 1991; 68: 276–81
   PubMedGoogle Scholar
• Poole S, Gaines Das R E, Dzau V J, Richards A M, Robertson J IS. The international standard for atrial natriuretic factor: calibration by an international collaborative study. Hypertension 1988; 12: 629–34
   PubMed Web of Science ®Google Scholar
• Maack T, Suzuki M, Almeida F A, Nussenzveig D, Scarborough R M, McEnroe G A, Lewicki J A. Physiological role of silent receptors of atrial natriuretic factor. Science 1987; 238: 675–8
   PubMed Web of Science ®Google Scholar
• Itoh H, Nakao K, Shiono S, Mukoyama M, Morii N, Sugawara A, Yamada T, Saito Y, Arai H, Kambayashi Y, Inouye K, Imura H. Conversion of β-human atrial natriuretic polypeptide into inhuman atrial natriuretic polypeptide in human plasma in vitro. Biochem Biophys Res Commun 1987; 143: 560–9
   PubMed Web of Science ®Google Scholar
• Lang R E, Dietz R, Merkel A, Unger T, Ruskoaho H, Ganten D. Plasma atrial natriuretic peptide values in cardiac disease. J Hypertens 1986; 4: S119–23, (suppl 2)
   Web of Science ®Google Scholar